Skip to Content
Merck
CN

C7124

Cryptolepine hydrate

≥98% (HPLC)

Synonym(s):

5-Methyl-5H-quindoline hydrate

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C16H12N2 · xH2O
CAS Number:
Molecular Weight:
232.28 (anhydrous basis)
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

AOTFRBDOIUZYCT-UHFFFAOYSA-N

SMILES string

O.Cn1c2ccccc2cc3nc4ccccc4c13

InChI

1S/C16H12N2.H2O/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14;/h2-10H,1H3;1H2

assay

≥98% (HPLC)

form

powder

color

purple

solubility

DMSO: ≥5 mg/mL

storage temp.

2-8°C

Biochem/physiol Actions

Cryptolepine hydrate is a cytoxic, anti-cancer, antimalarial agent

pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yumin Zhang et al.
Frontiers in cellular and infection microbiology, 11, 624745-624745 (2021-03-26)
Human babesiosis is a CDC reportable disease in the United States and is recognized as an emerging health risk in multiple parts of the world. The current treatment for human babesiosis is suboptimal due to treatment failures and unwanted side
Yu-Jing Lu et al.
Chemical communications (Cambridge, England), 47(17), 4971-4973 (2011-03-25)
A new switch-on fluorescent probe containing the natural product cryptolepine analogue benzofuroquinolinium moiety (binding scaffold) and a benzothiazole moiety (signalling unit) shows a remarkable fluorescence enhancement selective for the G-quadruplex nucleic acid structure. Binding studies revealed that the highly selective
Louise R Whittell et al.
Bioorganic & medicinal chemistry, 19(24), 7519-7525 (2011-11-08)
A series of mono- and di-substituted analogues of isocryptolepine have been synthesized and evaluated for in vitro antimalarial activity against chloroquine sensitive (3D7) and resistant (W2mef) Plasmodium falciparum and for cytotoxicity (3T3 cells). Di-halogenated compounds were the most potent derivatives
Rajendran C Gopalan et al.
Toxicology letters, 207(3), 322-325 (2011-09-29)
Malaria is a mosquito-borne infectious disease caused by the genus Plasmodium. It causes one million deaths per year in African children under the age of 5 years. There is an increasing development of resistance of malarial parasites to chloroquine and
João Lavrado et al.
Bioorganic & medicinal chemistry letters, 22(19), 6256-6260 (2012-08-29)
Cryptolepine derivatives containing alkyldiamine side-chains, 2, with potent inhibitory activity against Trypanosoma brucei brucei are reported. Compounds 2 showed improved activity and selectivity to T. b. brucei when compared to the lead compound. The most selective compound, 2k, presents a

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service